83 related articles for article (PubMed ID: 15081626)
1. Understanding adherence to neuroleptic treatment in schizophreniaí.
Vauth R; Löschmann C; Rüsch N; Corrigan PW
Psychiatry Res; 2004 Apr; 126(1):43-9. PubMed ID: 15081626
[TBL] [Abstract][Full Text] [Related]
2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
3. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
4. Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study.
Yamada K; Watanabe K; Nemoto N; Fujita H; Chikaraishi C; Yamauchi K; Yagi G; Asai M; Kanba S
Psychiatry Res; 2006 Jan; 141(1):61-9. PubMed ID: 16318875
[TBL] [Abstract][Full Text] [Related]
5. Cognitive strategies versus self-management skills as adjunct to vocational rehabilitation.
Vauth R; Corrigan PW; Clauss M; Dietl M; Dreher-Rudolph M; Stieglitz RD; Vater R
Schizophr Bull; 2005 Jan; 31(1):55-66. PubMed ID: 15888425
[TBL] [Abstract][Full Text] [Related]
6. Verbal memory, negative symptomatology and prediction of psychosocial functioning in schizophrenia.
Puig O; Penadés R; Gastó C; Catalán R; Torres A; Salamero M
Psychiatry Res; 2008 Feb; 158(1):11-7. PubMed ID: 18001844
[TBL] [Abstract][Full Text] [Related]
7. Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity.
Nakonezny PA; Byerly MJ; Rush AJ
Psychiatry Res; 2008 Jan; 157(1-3):259-63. PubMed ID: 17935793
[TBL] [Abstract][Full Text] [Related]
8. Attitudes toward medication in inpatients with schizophrenia: a cluster analytic approach.
Santone G; Rucci P; Muratori ML; Monaci A; Ciarafoni C; Borsetti G
Psychiatry Res; 2008 Apr; 158(3):324-34. PubMed ID: 18262656
[TBL] [Abstract][Full Text] [Related]
9. Adherence and nonadherence to antipsychotic medications.
Kozuki Y; Schepp KG
Issues Ment Health Nurs; 2005 May; 26(4):379-96. PubMed ID: 16020055
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.
Mishara AL; Goldberg TE
Biol Psychiatry; 2004 May; 55(10):1013-22. PubMed ID: 15121486
[TBL] [Abstract][Full Text] [Related]
11. One-year outcome and its prediction in first-episode schizophrenia--a naturalistic study.
Bachmann S; Bottmer C; Schroder J
Psychopathology; 2008; 41(2):115-23. PubMed ID: 18059113
[TBL] [Abstract][Full Text] [Related]
12. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.
Löffler W; Kilian R; Toumi M; Angermeyer MC
Pharmacopsychiatry; 2003 May; 36(3):105-12. PubMed ID: 12806568
[TBL] [Abstract][Full Text] [Related]
13. Course of adherence to medication and quality of life in people with schizophrenia.
Puschner B; Angermeyer MC; Leese M; Thornicroft G; Schene A; Kikkert M; Burti L; Tansella M; Becker T
Psychiatry Res; 2009 Feb; 165(3):224-33. PubMed ID: 19155070
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
[TBL] [Abstract][Full Text] [Related]
15. Guideline adherence in medication management of psychotic disorders: an observational multisite hospital study.
Weinmann S; Janssen B; Gaebel W
Acta Psychiatr Scand; 2005 Jul; 112(1):18-25. PubMed ID: 15952941
[TBL] [Abstract][Full Text] [Related]
16. Symptomatological and cognitive predictors of insight in chronic schizophrenia.
Nakano H; Terao T; Iwata N; Hasako R; Nakamura J
Psychiatry Res; 2004 Jun; 127(1-2):65-72. PubMed ID: 15261706
[TBL] [Abstract][Full Text] [Related]
17. Stability of set-shifting and planning abilities in patients with schizophrenia.
Tyson PJ; Laws KR; Roberts KH; Mortimer AM
Psychiatry Res; 2004 Dec; 129(3):229-39. PubMed ID: 15661316
[TBL] [Abstract][Full Text] [Related]
18. Correlations of attitudes toward antipsychotic drugs with insight and objective psychopathology in schizophrenia.
Rocca P; Crivelli B; Marino F; Mongini T; Portaleone F; Bogetto F
Compr Psychiatry; 2008; 49(2):170-6. PubMed ID: 18243890
[TBL] [Abstract][Full Text] [Related]
19. Adherence to medication and quality of life in people with schizophrenia: results of a European multicenter study.
Puschner B; Born A; Giessler A; Helm H; Leese M; Bindman JP; Gray RJ; Schene A; Kikkert M; Burti L; Marrella G; Becker T
J Nerv Ment Dis; 2006 Oct; 194(10):746-52. PubMed ID: 17041286
[TBL] [Abstract][Full Text] [Related]
20. [Adherence to antipsychotic medication in schizophrenia patients].
Baloush-Kleinman V; Poyurovsky M; Koren D; Schneidman M; Weizman A; Shnitt D
Harefuah; 2002 Dec; 141(12):1042-9, 1090. PubMed ID: 12534202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]